This site is intended for health professionals only

Covid-19

Lagevrio refused marketing authorisation by EMA for treatment of COVID
Waning COVID-19 vaccine effectiveness indicates possible need for continued preventative measures
Waning COVID-19 vaccine effectiveness indicates possible need for continued preventative measures
Joint Committee on Vaccination and Immunisation provides advice on next round of Covid boosters
Joint Committee on Vaccination and Immunisation provides advice on next round of Covid boosters
Heart failure risk significantly elevated after COVID-19 infection
Heart failure risk significantly elevated after COVID-19 infection
Anti-CD20 therapy linked to higher complication risk in COVID-19 for blood cancer patients
Anti-CD20 therapy linked to higher complication risk in COVID-19 for blood cancer patients
Remdesivir treatment produces improvement in COVID-19 severity biomarkers
Remdesivir treatment produces improvement in COVID-19 severity biomarkers
Trial finds molnupiravir treatment unable to reduce adverse COVID-19 outcomes among high-risk vaccinated patients
Trial finds molnupiravir treatment unable to reduce adverse COVID-19 outcomes among high-risk vaccinated patients
Favipiravir only benefits recovery in younger patients hospitalised with COVID-19
Favipiravir only benefits recovery in younger patients hospitalised with COVID-19
Not all post COVID-19 condition symptoms are specific to the virus
Not all post COVID-19 condition symptoms are specific to the virus
Vaccination decreases risk for development of post-COVID-19 condition
Vaccination decreases risk for development of post-COVID-19 condition
Higher levels of advanced colorectal cancer detected during COVID-19
Higher levels of advanced colorectal cancer detected during COVID-19
Nirmatrelvir and ritonavir combination appears safe in pregnancy
Nirmatrelvir and ritonavir combination appears safe in pregnancy
1 2 3 … 30


Most read

1
Feedback: Automation systems in your hospital
2
Merck agrees huge Vioxx settlement
3
Janssen-Cilag’s Stelara approved by NICE
4
Helapet introduce new, improved 20mm Vented Vial Adapter
5
Encouraging results for SLE treatment



Latest Issue

Read the latest issue >
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe

Download Hospital Pharmacy Europe free app

Download our app from the Apple App Store Download our app from Google Play

© Cogora 2023
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora